Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: CDRH personal conferencing

This article was originally published in The Gray Sheet

Executive Summary

CDRH personal conferencing: FDA's device center seeks industry participants to take part in evaluating the agency's electronic personal conferencing system ("The Gray Sheet" April 17, p. 4). Currently under trial within the center, the system "enables two people, at remote locations, to see and hear each other while reviewing and/or editing the same document shown on both computer screens" and allows "for the transmission of voice, video, and data displayed in a Windows application over a single communication link," FDA explains. In the next phase of testing, the agency plans to use the system in conjunction with device sponsors to "interactively and simultaneously discuss and modify documents which relate to new device applications," such as investigational device exemption protocols, deficiency letters, data summaries or labeling. For further information, contact Office of Information Systems Director Neil Goldstein at 301/594-4585...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel